Skip to main content
Beth Israel Deaconess Medical Center
Primary menu
  • Home
  • Our Team
  • Research
  • Fellowship & Education
  • Publications
  • News and Archives

In small-intestinal angiodysplasia with recurrent bleeding, thalidomide reduced bleeding episodes at 1 y.

Hakim, Aaron, and Joseph D Feuerstein. 2024. “In Small-Intestinal Angiodysplasia With Recurrent Bleeding, Thalidomide Reduced Bleeding Episodes at 1 Y.”. Annals of Internal Medicine 177 (3): JC32.
Publisher's Version

Abstract

Chen H, Wu S, Tang M, et al. Thalidomide for recurrent bleeding due to small-intestinal angiodysplasia. N Engl J Med. 2023;389:1649-1659. 37913505.

Last updated on 07/28/2025
PubMed

Selected Publications

  • Mistakes in therapeutic drug monitoring of biologics in IBD and how to avoid them
  • Proactive infliximab optimisation using a pharmacokinetic dashboard versus standard of care in patients with Crohn's disease: study protocol for a randomised, controlled, multicentre, open-label study (the OPTIMIZE trial).
  • Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectives.
  • A Comprehensive Literature Review and Expert Consensus Statement on Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease.
  • Higher Postinduction Infliximab Concentrations Are Associated With Improved Clinical Outcomes in Fistulizing Crohn's Disease: An ACCENT-II Post Hoc Analysis.
  • Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases.
More
Contact Us

330 Brookline Avenue

Boston, MA, 02215

Powered byOpenScholar®Admin Login